GP-Led Investments

Apogem Capital has been leading private equity GP-Led investments and LP secondaries for more than a decade, leveraging our deep middle market relationships to source and underwrite attractive opportunities. We seek opportunities where we believe the strength of the Apogem platform creates an advantage, generally resulting in limited competition, enhanced access to due diligence, and / or processes where we lead or co-lead the transaction.

Apogem is a leader in the GP-Led investment space, with more than a decade of experience across the complex and evolving private markets landscape, including single and multi asset continuation vehicles, fund restructurings, secondary direct investments, strip sales, and midlife preferred equity injections.

Apogem’s liquidity solutions program currently manages approximately $3.2 billion across commingled funds and custom accounts and have committed to 130+ GP-Led investments and LP secondary transactions since 2012, of which, approximately 60 have been GP-led investments.

Our GP-Led investment strategy typically targets:

• Strategies: buyout, growth
• Geographies: United States, Canada
• Diversification across transaction styles, industries, strategies, and portfolio / company size and maturity
• Trophy assets of Apogem’s high conviction GP relationships
• Strong alignment with the GP
• Companies with conservative capital structures, a proven management team, and multiple ways to create value
• Typical commitment: $10 – $100+ million across the platform

LP Secondaries

Apogem Capital has been leading private equity GP-Led investments and LP secondary transactions for more than a decade, leveraging our deep middle market relationships to source and underwrite attractive opportunities. We seek opportunities where we believe the strength of the Apogem platform creates an advantage, generally resulting in limited competition, enhanced access to due diligence, and / or processes where we lead the transaction. Apogem has experience across a range of LP secondaries opportunities. Due to our broad platform and focus on the middle market, we are often able to target opportunities outside of competitive processes with GPs that are traded less frequently on the secondary market and may have restricted buyer lists, which we believe results in more attractive pricing for our clients.

Apogem’s liquidity solutions program currently manages approximately $3.2 billion across commingled funds and custom accounts and have committed to 130+ GP-Led investments and LP secondary transactions since 2012, of which, approximately 65 have been LP secondary investments.

Our LP secondaries investment strategy typically targets:

• Strategies: buyout, growth
• Geographies: United States, Canada
• Diversification across transaction styles, industries, strategies, and portfolio / company size and maturity
• Highly funded investments at an earlier stage of value creation than typical secondaries
• Embedded value through negotiated and effective discounts
• Companies with conservative capital structures
• Backwards diversification across vintage years
• Typical commitment: $10 – $100+ million across the platform

GP Stakes

Launched in 2020, RidgeLake Partners is a strategic partnership between Apogem Capital and OA Private Capital. RidgeLake seeks to build a portfolio of minority equity investments in middle market GPs across private markets strategies.

We believe the RidgeLake team’s significant experience as both a GP stakes and private equity investor uniquely positions it to capitalize on the largely untapped opportunity in middle market GP stakes. We believe our focus on middle market GPs enables RidgeLake to access GPs at an attractive growth inflection point, where RidgeLake’s strategic capital can enable the GP to further scale its platform, offering clients attractive total return potential with a differentiated yield profile.

RidgeLake also seeks to be a value-added partner to GPs, offering a long-term capital solution while supporting partner GPs with strategic counsel and access to RidgeLake’s deep industry relationships.

RidgeLake’s GP stakes strategy typically targets:

• Minority equity investments (5-20%+) in middle market GPs, typically with AUM between $1 billion and $20 billion
• Target GP strategies: Private equity, private credit, secondaries, real assets and infrastructure
• Target GP geographies: North America and Europe
• Established middle market GPs sourced through Apogem and OA Private Capital’s deep relationships with leading fund managers
• Top-tier GPs with an established LP base and opportunities to increase AUM through fund size growth and / or expanding into adjacent strategies
• Opportunities with differentiated return potential and an attractive cash yield profile

RidgeLake Partners is a strategic partnership between OA Private Capital and Apogem Capital, a New York Life Investments affiliate. OA Private Capital and Apogem Capital are doing business as RidgeLake Partners under D/B/As (RidgeLake Partners (OA), and RidgeLake Partners (NYLI), respectively). This information is a summary, is subject to change, and speaks only as of the date hereof.